Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Nbn
REST API REST API
Rattus norvegicus
Nbn is differentially expressed in 42 experiments: 32 organism parts: 0 % liver / 0 % brain / 100 % lung, 0 % liver / 100 % brain / 0 % lung, ... (30 more);, 2 disease states: breast carcinoma, normal;, 2 cell types 5 compound treatments 2 clinical treatments and 10 other conditions.
Synonyms Nbs1, MGC93174
Orthologs NBN (Gallus gallus)   Nbn (Mus musculus)   ENSCING00000002421 (Ciona intestinalis)   nbn (Danio rerio)   NBN (Homo sapiens)   nbs (Drosophila melanogaster)   nbn (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term telomere maintenance, reciprocal meiotic recombination, DNA damage checkpoint, protein binding, apoptosis, cell proliferation, damaged DNA binding, Mre11 complex, intracellular, meiosis, positive regulation of cell proliferation, protein N-terminus binding, replication fork, double-strand break repair, transcription factor binding, DNA duplex unwinding, nuclear chromosome, telomeric region, molecular_function, cell cycle, nucleus, ATP-dependent DNA helicase activity, response to drug, chromosome, cell cycle checkpoint, nucleolus, nuclear inclusion body, regulation of fibroblast proliferation, in utero embryonic development, blastocyst growth, mitotic cell cycle G2/M transition DNA damage checkpoint, neuromuscular process controlling balance, negative regulation of neuron differentiation, G2/M transition checkpoint, isotype switching, positive regulation of kinase activity, positive regulation of protein autophosphorylation, mitotic cell cycle G1/S transition checkpoint
InterPro Term SMAD_FHA_domain, Nibrin_met, FHA_dom, BRCT, DNA-repair_Nbs1_C
UniProt Accession Q9JIL9
Search EB-eye ENSRNOG00000008580
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-2880, E-GEOD-13793, E-GEOD-19830, E-GEOD-2354, E-AFMX-7, ... (11 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell type

studied in E-TABM-130

Factor Value U/D Experiments
Sertoli cell
1
1
E-TABM-130
spermatocyte
1
E-TABM-130


Disease state

studied in E-GEOD-1872

Factor Value U/D Experiments
breast carcinoma
1
E-GEOD-1872
normal
16
1
E-GEOD-1872


Compound treatment

studied in E-MTAB-77, E-GEOD-4028, E-GEOD-22647

Factor Value U/D Experiments
AICAR
1
E-GEOD-22647
control
1
1
5
E-MTAB-77, E-GEOD-4028
dexamethasone
1
E-GEOD-22647
perfluorododecanoic acid
1
E-MTAB-77
diethylstilbestrol
1
E-GEOD-4028


Clinical treatment

studied in E-GEOD-7002

Factor Value U/D Experiments
inhalation
1
E-GEOD-7002
instillation
1
E-GEOD-7002


Developmental stage

studied in E-MEXP-570, E-GEOD-20245

Factor Value U/D Experiments
day E16 embryo
1
E-GEOD-20245
E16
1
E-MEXP-570
E12.5
1
E-MEXP-570
day E14 embryo
1
E-GEOD-20245


Diet
studied in E-GEOD-21681

Genotype
studied in E-GEOD-20214

Growth condition
studied in E-TABM-501

Phenotype
studied in E-GEOD-7041, E-MIMR-541, E-GEOD-2275

protocol
studied in E-GEOD-20895

Protocol type
studied in E-MEXP-1565

Strain or line
studied in E-GEOD-7041, E-MTAB-322, E-TABM-457, E-TABM-458, E-MTAB-323 ... (5 experiments)

tissue region
studied in E-GEOD-21681

Treatment
studied in E-GEOD-15184, E-GEOD-16981, E-GEOD-19909

Processing time: 0.609 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM